ACTG/ Advancing Clinical Therapeutics Globally for HIV and Other Infections

Established in 1987, the ACTG Network (Advancing Clinical Therapeutics Globally for HIV and Other Infections) is the world’s largest and longest-running HIV clinical trials network. The ACTG conducts groundbreaking research to improve the treatment of HIV and its co-infections, including tuberculosis and viral hepatitis, as well as its co-morbidities. The ACTG also seeks to advance approaches to ultimately cure HIV. ACTG clinical trial units in 12 countries serve as major resources for HIV research and training/education in their communities. ACTG studies have had a profound impact on the well-being of people living with HIV worldwide, helping to establish current paradigms for treating HIV and contributing to dramatic decreases in HIV-related mortality worldwide.